Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Inte
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8019-8021
10.1182/blood-2022-167411